Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra J Shin

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Clinical Breast Cancer|June 6, 2018
Hot Spot and Whole-Tumor Enumeration of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes Utilizing Digital Image Analysis Is Prognostic in Triple-Negative Breast CancerPatrick J McIntire, Lina Irshaid, Yifang Liu, et al.
Human Pathology|September 15, 2014
MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid featuresTimothy M D'Alfonso, Juan Miguel Mosquera, Theresa Y MacDonald, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 21, 2013
In search of the ideal immunopanel to distinguish metastatic mammary carcinoma from primary lung carcinoma: a tissue microarray study of 207 casesKathy R Kawaguchi, Fang-I Lu, Rachel Kaplan, et al.
Clinical Breast Cancer|February 4, 2014
Impact of oncotype DX recurrence score in the management of breast cancer casesMichaela T Nguyen, Alexander Stessin, Himanshu Nagar, et al.
Human Pathology|November 2, 2018
Hotspot enumeration of CD8+ tumor-infiltrating lymphocytes using digital image analysis in triple-negative breast cancer yields consistent resultsPatrick J McIntire, Elaine Zhong, Ami Patel, et al.
The Breast Journal|May 31, 2017
Characterization of CD34-deficient myofibroblastomas of the breastTimothy M D'Alfonso, Shivakumar Subramaniyam, Paula S Ginter, et al.
Breast Cancer Research and Treatment|June 19, 2013
BreastPRS is a gene expression assay that stratifies intermediate-risk Oncotype DX patients into high- or low-risk for disease recurrenceTimothy M D'Alfonso, Ryan K van Laar, Linda T Vahdat, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 2, 2020
Adenomyoepithelial tumors of the breast: molecular underpinnings of a rare entityPaula S Ginter, Patrick J McIntire, Boaz Kurtis, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 6, 2013
Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancersAlla Gabriella Wernicke, Sonal Varma, Eleni A Greenwood, et al.
Human Pathology|July 2, 2013
Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situSandra J Shin, Aseem Lal, Sandy De Vries, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Clinical Breast Cancer|June 6, 2018
Hot Spot and Whole-Tumor Enumeration of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes Utilizing Digital Image Analysis Is Prognostic in Triple-Negative Breast CancerPatrick J McIntire, Lina Irshaid, Yifang Liu, et al.
Human Pathology|September 15, 2014
MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid featuresTimothy M D'Alfonso, Juan Miguel Mosquera, Theresa Y MacDonald, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 21, 2013
In search of the ideal immunopanel to distinguish metastatic mammary carcinoma from primary lung carcinoma: a tissue microarray study of 207 casesKathy R Kawaguchi, Fang-I Lu, Rachel Kaplan, et al.
Clinical Breast Cancer|February 4, 2014
Impact of oncotype DX recurrence score in the management of breast cancer casesMichaela T Nguyen, Alexander Stessin, Himanshu Nagar, et al.
Human Pathology|November 2, 2018
Hotspot enumeration of CD8+ tumor-infiltrating lymphocytes using digital image analysis in triple-negative breast cancer yields consistent resultsPatrick J McIntire, Elaine Zhong, Ami Patel, et al.
The Breast Journal|May 31, 2017
Characterization of CD34-deficient myofibroblastomas of the breastTimothy M D'Alfonso, Shivakumar Subramaniyam, Paula S Ginter, et al.
Breast Cancer Research and Treatment|June 19, 2013
BreastPRS is a gene expression assay that stratifies intermediate-risk Oncotype DX patients into high- or low-risk for disease recurrenceTimothy M D'Alfonso, Ryan K van Laar, Linda T Vahdat, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 2, 2020
Adenomyoepithelial tumors of the breast: molecular underpinnings of a rare entityPaula S Ginter, Patrick J McIntire, Boaz Kurtis, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 6, 2013
Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancersAlla Gabriella Wernicke, Sonal Varma, Eleni A Greenwood, et al.
Human Pathology|July 2, 2013
Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situSandra J Shin, Aseem Lal, Sandy De Vries, et al.
Pageof 8